Welcome to LookChem.com Sign In|Join Free
  • or
CFI-402257 is a potent and selective inhibitor of the protein kinase CK1, which plays a significant role in cancer progression and neurodegenerative diseases. It has been shown to inhibit CK1 delta and epsilon isoforms with high potency, while exhibiting minimal activity against a range of other kinases. Its strong ability to inhibit the growth of cancer cells in preclinical studies makes it a promising candidate for the development of new anti-cancer therapies. Furthermore, its potential in treating neurodegenerative diseases is being explored, as CK1 has been implicated in the pathogenesis of various neurodegenerative conditions.

1610759-22-2

Post Buying Request

1610759-22-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1610759-22-2 Usage

Uses

Used in Pharmaceutical Industry:
CFI-402257 is used as an anti-cancer agent for its strong ability to inhibit the growth of cancer cells. Its high potency in inhibiting CK1 delta and epsilon isoforms makes it a promising candidate for the development of new anti-cancer therapies.
Used in Neurodegenerative Disease Treatment:
CFI-402257 is used as a potential therapeutic agent for treating neurodegenerative diseases, as CK1 has been implicated in the pathogenesis of various neurodegenerative conditions. Its potential in this area is currently being explored through ongoing research.

Check Digit Verification of cas no

The CAS Registry Mumber 1610759-22-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,0,7,5 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1610759-22:
(9*1)+(8*6)+(7*1)+(6*0)+(5*7)+(4*5)+(3*9)+(2*2)+(1*2)=152
152 % 10 = 2
So 1610759-22-2 is a valid CAS Registry Number.

1610759-22-2Downstream Products

1610759-22-2Relevant academic research and scientific papers

PYRAZOLOPYRIMIDINE COMPOUNDS

-

, (2015/06/03)

The present teachings provide a compound represented by the following structural formula: (Formula (I)); or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1610759-22-2